Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-24 @ 10:45 PM
NCT ID:
NCT05597735
Eligibility Criteria:
Inclusion Criteria:
* Adults and adolescents (14 years old and older) with laboratory-confirmed (PCR if available) or highly suspected monkeypox virus infection of any duration
* At least one visible active skin or mucosal lesion
* Reachable via smartphone (for video calls) for outpatient participants
* Signed informed consent
Exclusion Criteria:
* Current or planned use of another investigational drug at any point during study participation.
* Ongoing treatment which cannot be interrupted and for which a major interaction has been described with tecovirimat
* Patients who, in the judgement of the investigator, will be at significantly increased risk as a result of participation in the study (for example: if the investigator judges that an antiviral treatment is indicated in the framework of compassionate therapeutic access in Switzerland).
* Hypersensitivity to tecovirimat
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
14 Years
Study:
NCT05597735
Study Brief:
Protocol Section:
NCT05597735